Indication
Anal Cancer Stage I (AJCC v8)
2 clinical trials
1 product
4 drugs
Clinical trial
A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)Status: Recruiting, Estimated PCD: 2029-12-31
Drug
UTD1Drug
fluorouracilProduct
MitomycinClinical trial
Risk-Adapted Therapy for HIV-Associated Anal CancerStatus: Recruiting, Estimated PCD: 2029-09-15
Drug
DocetaxelDrug
T-VEC